Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Schizophrenia

Free Subscription 21.04.2020 1 Biol Psychiatry 2 J Clin Psychiatry 2 J Nerv Ment Dis 3 Mol Psychiatry 1 Neuropsychopharmacology 1 Psychiatry Res 1 Psychol Med 6 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. SANFELICI R, Dwyer DB, Antonucci LA, Koutsouleris N, et al
   Individualized Diagnostic and Prognostic Models for Patients With Psychosis Risk Syndromes: A Meta-analytic View on the State of the Art.
   Biol Psychiatry. 2020 Feb 20. pii: S0006-3223(20)30098.
   PubMed         Abstract available
   
   

   
   J Clin Psychiatry

2. CORRELL CU
   Current Treatment Options and Emerging Agents for Schizophrenia.
   J Clin Psychiatry. 2020;81.
   PubMed         Abstract available
   
   
3. CORRELL CU
   Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences.
   J Clin Psychiatry. 2020;81.
   PubMed         Abstract available
   
   

   
   J Nerv Ment Dis

4. 
   Facilitating the Delivery of Cognitive Remediation in First-Episode Psychosis: Pilot Study of a Home-Delivered Web-Based Intervention: Erratum.
   J Nerv Ment Dis. 2020;208:439.
   PubMed        
   
   
5. ALLEN AR, Hagen KM
   Trauma and Suicide: A Pilot Study Assessing Risk in Adults Diagnosed With Schizophrenia Spectrum Disorders.
   J Nerv Ment Dis. 2020;208:431-434.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

6. MARQUES TR, Ashok AH, Angelescu I, Borgan F, et al
   GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513.
   Mol Psychiatry. 2020 Apr 15. pii: 10.1038/s41380-020-0711.
   PubMed         Abstract available
   
   
7. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
   Differences in fractional anisotropy between the patients with schizophrenia and healthy comparison subjects.
   Mol Psychiatry. 2020;25:697-698.
   PubMed        
   
   
8. LICINIO J
   Advances in schizophrenia research: first special issue, 2020.
   Mol Psychiatry. 2020;25:699-700.
   PubMed        
   
   

   
   Neuropsychopharmacology

9. YAO L, Li F, Liu J, Liao W, et al
   Correction: Functional brain networks in never-treated and treated long-term Ill schizophrenia patients.
   Neuropsychopharmacology. 2020 Apr 17. pii: 10.1038/s41386-020-0673.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

10. ZANDIFAR A, Badrfam R
    COVID-19: Considering the prevalence of schizophrenia in the coming decades.
    Psychiatry Res. 2020;288:112982.
    PubMed        
    
    

    
    Psychol Med

11. BURGER TJ, Schirmbeck F, Vermeulen JM, Quee PJ, et al
    Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis.
    Psychol Med. 2020 Apr 15:1-11. doi: 10.1017/S0033291720000719.
    PubMed         Abstract available
    
    

    
    Schizophr Res

12. BARRY AB, Koeppel JA, Ho BC
    Impulsive decision making, brain cortical thickness and familial schizophrenia risk.
    Schizophr Res. 2020 Apr 15. pii: S0920-9964(20)30206.
    PubMed         Abstract available
    
    
13. PAQUIN V, Lemire M, King S
    Ecosystem approaches to the risk for schizophrenia.
    Schizophr Res. 2020 Apr 10. pii: S0920-9964(20)30168.
    PubMed        
    
    
14. VERNAL DL, Boldsen SK, Lauritsen MB, Correll CU, et al
    Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study.
    Schizophr Res. 2020 Apr 13. pii: S0920-9964(20)30155.
    PubMed         Abstract available
    
    
15. VIHER PV, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Altered diffusion in motor white matter tracts in psychosis patients with catatonia.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30120.
    PubMed         Abstract available
    
    
16. MINICHINO A, Brondino N, Solmi M, Del Giovane C, et al
    The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30101.
    PubMed         Abstract available
    
    
17. QIAN N, Lipkin RM, Kaszowska A, Silipo G, et al
    Computational modeling of excitatory/inhibitory balance impairments in schizophrenia.
    Schizophr Res. 2020 Apr 11. pii: S0920-9964(20)30133.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: